* ICU Medical Inc ICUI.OQ ICUI.O is expected to show a
rise in
quarterly revenue when it reports results on November 7.
* The San Clemente California-based company is expected to
report
a 68.1% increase in revenue to $565 million from $336.06
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for ICU Medical Inc is
for
earnings of $1.46 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.
* Wall Street's median 12-month price target for ICU Medical
Inc
is $225, above its last closing price of $136.41.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 1.65 1.66 1.37 Missed -17.5
Mar. 31 2022 1.78 1.78 1.82 Beat 2.1
Dec. 31 2021 1.65 1.64 1.82 Beat 10.8
Sep. 30 2021 1.80 1.80 2.07 Beat 15.2
Jun. 1.65 1.64 1.88 Beat 14.6
30 2021
Mar. 31 2021 1.50 1.50 1.62 Beat 7.8
Dec. 31 2020 1.52 1.51 1.77 Beat 17.2
Sep. 30 2020 1.31 1.31 1.90 Beat 45.4
This summary was machine generated November 5 at 03:16 GMT. All
figures in US dollars unless otherwise stated